Tiziana Life Sciences Ltd (TLSA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2020 | 06-2020 | 12-2019 | 06-2019 | 12-2018 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 65,824 | 8,934 | 200 | 572 | 5,304 |
| Receivables | 3,567 | 3,135 | 1,140 | 1,378 | 1,042 |
| Other current assets | 785 | 0 | 165 | 0 | 567 |
| TOTAL | $70,176 | $12,069 | $1,505 | $1,950 | $6,913 |
| Non-Current Assets | |||||
| PPE Net | N/A | 53 | 6 | 48 | 46 |
| Other Non-Current Assets | 120 | 562 | 434 | 739 | 0 |
| TOTAL | $120 | $615 | $440 | $787 | $46 |
| Total Assets | $70,656 | $13,020 | $2,378 | $2,696 | $6,920 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 5,590 | 5,704 | 6,396 | 6,078 | 6,401 |
| Other current liabilities | 2,125 | 401 | 676 | N/A | 0 |
| TOTAL | $7,980 | $6,505 | $7,351 | $6,189 | $6,401 |
| Non-Current Liabilities | |||||
| TOTAL | $N/A | $N/A | $N/A | $356 | $N/A |
| Total Liabilities | $8,270 | $6,887 | $7,892 | $6,545 | $6,401 |
| Shareholders' Equity | |||||
| Common Shares | 10,794 | 6,195 | 8,599 | 5,264 | 8,592 |
| Retained earnings | -84,646 | -58,732 | -60,044 | -50,725 | -50,721 |
| Other shareholders' equity | 24,417 | 11,032 | 6,000 | 8,318 | 1,786 |
| TOTAL | $62,386 | $6,133 | $-5,514 | $-3,849 | $519 |
| Total Liabilities And Equity | $70,656 | $13,020 | $2,378 | $2,696 | $6,920 |